Search for: "Novartis Ag"
Results 361 - 380
of 440
Sort by Relevance
|
Sort by Date
20 Aug 2009, 1:06 pm
For example, in 2004, Teva filed and won a lawsuit against Novartis International AG. [read post]
27 Jul 2009, 7:18 am
: Whirlpool Corporation v Kenwood Ltd (IPKat) EWHC (Pat): EP 258 valid in Netherlands but not UK: Novartis AG and Cibavision AG v Johnson & Johnson Medical Ltd & Ors (IPKat) EWHC (QB): When lawfully seized items can’t be retained under s 22 Police and Criminal Evidence Act 1984 (1709 Copyright Blog) United States US General Obama IP vacancies (IP Frontline) Kappos confirmation hearing set for 29 July (IP Watchdog) (IAM) (Peter Zura's 271… [read post]
23 Jul 2009, 2:30 am
It was decided rather earlier this month, but the ruling of Mr Justice Kitchin in Novartis AG and Cibavision AG v Johnson & Johnson Ltd and another [2009] EWHC 1671 (Pat) has taken a while to reach the top of the IPKat's must-blog pile. 356 paragraphs can take a long time for a Kat to read and, though he hates to admit it, even longer to get the hang of what it's all about.In brief, Novartis claimed that J&J's Acuvue Oasys products… [read post]
20 Jul 2009, 2:00 pm
To reassess the CV safety of tegaserod, teagaserod-treated patients (pts) in the Intermountain Healthcare database were identified (n = 2603), matched 1:6 with untreated (n = 15,618) patients by age, sex, and date of tegaserod initiation, and followed for an average of 2.5 years.... [read post]
13 Jul 2009, 6:45 am
(Afro-IP) Spain Trade mark cancellation and damages: a matter of (bad) faith (Class 46) United Kingdom EWHC (Pat): No ruling on hypothetical issue: MMI Research Ltd v Cellxion Ltd (IPKat) EWHC (Pat): EP 258 valid in Netherlands but not UK: Novartis AG and Cibavision AG v Johnson & Johnson Medical Ltd & Ors (PatLit) EWHC: Trial judge says ‘Boileau’ to patent licence; appeal court agrees: Oxonica Energy Ltd v Neuftec… [read post]
25 Jun 2009, 4:29 am
Novartis Pharmaceuticals Corp., 541 F. [read post]
14 May 2009, 1:45 pm
The deals included Novartis AG's (NVS) acquisition of Eon Labs in 2005, Electronic Arts Inc. [read post]
1 May 2009, 9:00 am
Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax (Naproxen)… [read post]
6 Apr 2009, 8:20 am
., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law… [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
4 Mar 2009, 2:47 am
High Court (Administrative Court) Haw, R (on the application of) v Southwark Crown Court & Ors [2009] EWHC 379 (Admin) (03 March 2009) High Court (Patents Court) Novartis AG v Dexcel-Pharma Ltd [2009] EWHC 336 (Pat) (03 March 2009) Source: www.bailii.org [read post]
23 Jan 2009, 9:59 pm
By Jason Derry --Peptimmune and Novartis Sign $500 Million Deal Peptimmune Inc. and Novartis AG recently announced a licensing deal for Peptimmune's multiple sclerosis drug candidate, PI-2301. [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
22 Jan 2009, 2:06 am
As we reported yesterday, the California Supreme Court denied the petitions for review in Wyeth v. [read post]
19 Jan 2009, 4:14 pm
30 Dec 2008, 1:17 pm
***ALSOhttp://ipbiz.blogspot.com/2008/11/novartis-makes-plans-for-diovan-going.html [read post]
8 Dec 2008, 12:50 pm
.; and Foradil, from Novartis AG - will be reviewed by outside medical advisers to the FDA at a two-day hearing next week in Rockville, Md.A fourth drug, Advair made by GlaxoSmithKline, had no increased risk of respiratory complications, FDA staff said. [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending September… [read post]
2 Dec 2008, 10:07 pm
Those clients are: Novartis AG, Panasonic Corp., Qatar Investment Authority, and UBS AG. [read post]
